NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1st May 2024

Concepts

• runcorn
• pharmaceutical products
• nhs framework agreement
• branded medicines - proprietary category tender
• nhs framework agreement for branded medicines - proprietary category tender - 1st
• branded medicines - proprietary category tender - 1st
• may
• nhs framework agreement for branded medicines - proprietary category tender - 01
• cm/phr/22/5683/00 - nhs framework agreement for branded medicines - proprietary category tender: period of framework agreement
• may 2025

Location

Description

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 03 - Framework Agreement and Terms and Conditions - National Branded Proprietary Category -1st May 2025 Document No. 03 - Framework Agreement and Terms and Conditions - National Branded Proprietary Category -1st May 2025.docx Document No. 08 - Confidential Information Schedule - CM_PHR_22_5683 Document No. 08 - Confidential Information Schedule - CM_PHR_22_5683.xls Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-22-5683 Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-22-5683.xls Document No. 02 - Terms of offer Document No. 02 - Terms of offer.docx Document No. 10 - Participating Authorities - CM_PHR_22_5683 Document No. 10 - Participating Authorities - CM_PHR_22_5683.xls Document No. 06 - Form of Offer - CM_PHR_22_5683 Document No. 06 - Form of Offer - CM_PHR_22_5683.doc Document No. 05b - Tender Product Listing and Usage - CM-PHR-22-5683 Document No. 05b - Tender Product Listing and Usage - CM-PHR-22-5683.xlsx Document No. 05a - Selectt Offer Schedule CM_PHR_22_5683_00 Document No. 05a - Selectt Offer Schedule CM_PHR_22_5683_00.xml Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.doc Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx Document No. 01 - Invitation to offer covering letter Document No. 01 - Invitation to offer covering letter.docx Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023) Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).docx Document No. 05d - Selectt Offer Schedule Instructions - CM-PHR-22-5683 Document No. 05d - Selectt Offer Schedule Instructions - CM-PHR-22-5683.docx Document No. 05e - Supplementary Usage Data for Buprenorphine Methylphenidate and Oxycodone Document No. 05e - Supplementary Usage Data for Buprenorphine Methylphenidate and Oxycodone.xlsx Document No. 07a - Quality Control Technical Sheet Document No. 07a - Quality Control Technical Sheet.doc Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule.doc